SE-Therapeutics
Innovative intracellular drug delivery
- B2B
About SE-Therapeutics
Innovative technology for intracellular delivery of antibodies and gene editing RNPs to provide life-changing cures for cancer and neurodegenerative disorders
Key facts
- Industry
- Biotechnology Research
- Company size
- 1–10 employees
- Headquarters
- Évry, Île-de-France, France
- Founded
- 2022
- Revenue
- $3.4M – $26.9MTamtam estimate
- Website
- setherapeutics.com
SE-Therapeutics at a glance
SE-Therapeutics is a B2B company in the Biotechnology Research industry, headquartered in Évry, Île-de-France, France.
SE-Therapeutics was founded in 2022.
SE-Therapeutics has 1–10 employees.
SE-Therapeutics's revenue is $3.4M – $26.9M (Tamtam estimate).
Selling to companies like SE-Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies